Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Teva
McKinsey
US Department of Justice
Baxter
Merck
Cerilliant
Express Scripts
Federal Trade Commission
Argus Health

Generated: February 24, 2018

DrugPatentWatch Database Preview

BETAPAR Drug Profile

« Back to Dashboard

Which patents cover Betapar, and when can generic versions of Betapar launch?

Betapar is a drug marketed by Schering and is included in one NDA.

The generic ingredient in BETAPAR is meprednisone. Additional details are available on the meprednisone profile page.
Summary for BETAPAR
Drug patent expirations by year for BETAPAR

US Patents and Regulatory Information for BETAPAR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Schering BETAPAR meprednisone TABLET;ORAL 016053-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Chinese Patent Office
Teva
Covington
Accenture
Johnson and Johnson
Fuji
Citi
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot